Company Filing History:
1 out of 273 
1 out of 1,290 
Years Active: 2022
Title: Shuichi Asakawa: Innovator in Antitumor Peptide Research
Introduction
Shuichi Asakawa is a prominent inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic peptides for medical applications. His innovative work has led to the creation of a patented antitumor peptide that holds promise for cancer treatment.
Latest Patents
Asakawa's most notable patent is titled "Antitumor peptide and use thereof." This synthetic peptide includes a CTLA4-SP-related sequence and an amino acid sequence that functions as a cell-penetrating peptide. The synthetic peptide has a total number of amino acid residues of 100 or less. This innovation represents a significant advancement in the search for effective cancer therapies.
Career Highlights
Throughout his career, Shuichi Asakawa has worked with reputable organizations, including Toagosei Company, Ltd. and The University of Tokyo. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Asakawa has collaborated with notable colleagues, including Nahoko Baileykobayashi and Tetsuhiko Yoshida. These partnerships have further enhanced his research and development efforts in the field of synthetic peptides.
Conclusion
Shuichi Asakawa's work in the development of antitumor peptides showcases his dedication to advancing medical science. His innovative contributions continue to inspire future research in cancer treatment.